P L A N T S for Lyfe

02/05/2026

A study out of North Carolina reviewed 5448 infants with Medicaid insurance and found that 1671 had meconium (first stool) that screened positive for cannabis. Compared to the 2599 infants who were negative for all substances, the cannabis exposed infants, had no difference in their well childcare attendance, emergency department visits, and developmental delay diagnosis during the first two years of life.

These findings are reassuring and give more evidence that cannabis used during pregnancy should not be criminalized.

If you can find no safe alternatives to treat your medical conditions while pregnant and choose to consume cannabis via your lungs, please use an electronic vaporizer made for dry botanicals to protect you and your child from toxic combustion byproducts.

We examined the association between in utero cannabis exposure and well child care (WCC) attendance, emergency department (ED) visits, and developmental delay (DD) diagnosis during the first two years of life.

01/26/2026

We’re bringing advocacy training to the people.

The Pressure Play Workshop is a civic education session focused on how policy actually moves and how communities apply pressure with purpose, not noise.

📅 January 27, 2026
🕖 7:00 PM ET
💻 Virtual (weather adjustment) Register in advance for this meeting: https://us06web.zoom.us/meeting/register/y2kU3DDFRWS-CItpq75AAQ

Hosted by the Georgia Medical Cannabis Society, with Peachtree NORML serving as co-host, this session welcomes patients, advocates, and stakeholders who want to be informed and prepared when action matters.

This is Session One of the 2026 series and part of a six-session course offered throughout the year.

Learn more and support the work at gmcsimpact.com.

01/26/2026

01/19/2026

Interestingly, these synthetic cannabinoids were created in the 1970s by scientists after they could no longer get easy access to the plant once Niixon put cannabis on the Controlled Substances List.

Unfortunately, bad actors seized their chemical inventions to make a quick buck and endanger lives because these agents bind to cannabinoid receptors much more strongly than the plant does.

And yet, a large amount of American cannabinoid research is based on them.

Synthetic cannabinoids will get you into the ballpark, but only the plant can get you onto the bases.

“Cannabimimetic agents are substances that act as agonists at the cannabinoid receptor type 1 (CB1 receptor). This means they can mimic the effects of cannabinoids, which are compounds found in cannabis.”

The Drug Enforcement Administration is publishing this final rule to amend its regulations related to "cannabimimetic agents" by including the term's definition, identifying 18 additional substances that meet the definition, and consolidating most existing administration controlled substances...

01/06/2026

We invite you to join us at the Georgia State Capitol on January 12th for a day of advocacy; additional information is available upon request.

01/06/2026

“Meanwhile, a leading ma*****na prohibitionist group says it’s retained the legal services of Trump’s former attorney general, Bill Barr, to sue to reverse federal ma*****na rescheduling if and when the pending rule is finalized.

And they’ll also be filing a petition through the administrative process to keep cannabis strictly prohibited.”

The Drug Enforcement Administration (DEA) says the ma*****na rescheduling appeal process “remains pending” despite President Donald Trump’s recent executive order directing the attorney general to finish the job “in the most expeditious manner.” DEA and reform proponents on Monday submitte...